We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cumberland Pharmaceutical Inc | NASDAQ:CPIX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 3.27% | 1.58 | 1.55 | 1.85 | 1.84 | 1.57 | 1.57 | 8,849 | 22:11:55 |
|
|
Date of report (date of earliest event reported): September 21, 2018 (September 19, 2018)
|
|
|||
Tennessee
|
001-33637
|
62-1765329
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
|
|
|
2525 West End Avenue, Suite 950, Nashville, Tennessee 37203
|
|||
(Address of principal executive offices) (Zip Code)
|
|||
|
|
||
(615) 255-0068
|
|||
Registrant's telephone number, including area code:
|
|
|
|
|
|
|
|
|
Cumberland Pharmaceuticals Inc.
|
|
|
|
|
Dated: September 21, 2018
|
By: /s/ Michael Bonner
|
|
|
|
|
|
Name: Michael Bonner
|
|
|
Title: Chief Financial Officer
|
|
|
|
1 Year Cumberland Pharmaceutical Chart |
1 Month Cumberland Pharmaceutical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions